Impact of bee venom enzymes on diseases and immune responses

Md Sakib Hossen, Ummay Mahfuza Shapla, Siew Hua Gan, Md Ibrahim Khalil

Research output: Contribution to journalReview ArticleOtherpeer-review

69 Citations (Scopus)

Abstract

Bee venom (BV) is used to treat many diseases and exhibits anti-inflammatory, anti-bacterial, antimutagenic, radioprotective, anti-nociceptive immunity promoting, hepatocyte protective and anti-cancer activity. According to the literature, BV contains several enzymes, including phospholipase A2 (PLA2), phospholipase B, hyaluronidase, acid phosphatase and α-glucosidase. Recent studies have also reported the detection of different classes of enzymes in BV, including esterases, proteases and peptidases, protease inhibitors and other important enzymes involved in carbohydrate metabolism. Nevertheless, the physiochemical properties and functions of each enzyme class and their mechanisms remain unclear. Various pharmacotherapeutic effects of some of the BV enzymes have been reported in several studies. At present, ongoing research aims to characterize each enzyme and elucidate their specific biological roles. This review gathers all the current knowledge on BV enzymes and their specific mechanisms in regulating various immune responses and physiological changes to provide a basis for future therapies for various diseases.

Original languageEnglish
Article number25
Number of pages16
JournalMolecules
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 2017
Externally publishedYes

Keywords

  • Apis Mellifera
  • Bee Venom
  • Enzymes
  • Pharmacotherapeutics
  • Protein
  • Toxin

Cite this